Currency:

18.08.2017

 Currency - RUR

Basic Indexes:

18.08.2017

DJIA 0.00 0.00 0.00
NASDAQ 0.00 0.00 0.00
RTSI 0.00 0.00 0.00


17-07-24-2

17-07-20

17-06-22

17-07-03-1

17-06-16

НГСХА-баннер

Russian company develops advanced thrombosis therapy

Home » News Archive » Russian company develops advanced thrombosis therapy
15.02.2017
Healthcare

FK Laboratories, a domestic biotech developer, is working on its novel drug candidate to prevent and treat thromboses, a serious health condition for millions of people. 

Thrombosis is the formation of solid blood clots (thrombi) in the blood vessels which threatens to disrupt normal blood circulation. What poses the greatest threat to the human body in thrombus formation is a condition in which a thrombus suddenly breaks free from the wall of a vessel to become free-floating; it may get right into the heart or the lungs or the brain.

The drug candidate FK Laboratories has recently come up with represents the next generation of highly specific direct thrombin inhibitor, the solution most widely used to deal with the pathology. “The medicine under development is offering a range of key advantages, including oral administering, no toxicity, and high specificity,” said Elizaveta Rozhdestvenskaya, the executive director of Primer Capital, the fund that invested in the developer at the end of last year.

Currently thrombus-related pathology is said to be responsible for about 40% of adults’ premature deaths.

Source: Marchmont

   
Back to top
Poll

Will the recent creation of several autonomous OSs in RF influence the growth of the domestic IT sector?

Результаты

Загрузка ... Загрузка ...
Subscribe
  • Подписка на рассылку / Subscribe to Newsletter

    Ваша почта / Your e-mail

Information Partners

Баннер_РБК_02

Zhiguli-Valley-bunner

Ankudonovka

Sarov

Logo_marchmont_rectangle_red

logo_rabota_ru_160x38

НТА-Приволжье

clever

бизнес-движение колесо

Копия Логотип МОЗГОВО

icann bunner 1